Correlation Between Rafarma Pharmaceuticals and 4Front Ventures
Can any of the company-specific risk be diversified away by investing in both Rafarma Pharmaceuticals and 4Front Ventures at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rafarma Pharmaceuticals and 4Front Ventures into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rafarma Pharmaceuticals and 4Front Ventures Corp, you can compare the effects of market volatilities on Rafarma Pharmaceuticals and 4Front Ventures and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rafarma Pharmaceuticals with a short position of 4Front Ventures. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rafarma Pharmaceuticals and 4Front Ventures.
Diversification Opportunities for Rafarma Pharmaceuticals and 4Front Ventures
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Rafarma and 4Front is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Rafarma Pharmaceuticals and 4Front Ventures Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 4Front Ventures Corp and Rafarma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rafarma Pharmaceuticals are associated (or correlated) with 4Front Ventures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 4Front Ventures Corp has no effect on the direction of Rafarma Pharmaceuticals i.e., Rafarma Pharmaceuticals and 4Front Ventures go up and down completely randomly.
Pair Corralation between Rafarma Pharmaceuticals and 4Front Ventures
Given the investment horizon of 90 days Rafarma Pharmaceuticals is expected to generate 1.36 times more return on investment than 4Front Ventures. However, Rafarma Pharmaceuticals is 1.36 times more volatile than 4Front Ventures Corp. It trades about 0.16 of its potential returns per unit of risk. 4Front Ventures Corp is currently generating about -0.11 per unit of risk. If you would invest 3.80 in Rafarma Pharmaceuticals on September 18, 2024 and sell it today you would earn a total of 5.20 from holding Rafarma Pharmaceuticals or generate 136.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Rafarma Pharmaceuticals vs. 4Front Ventures Corp
Performance |
Timeline |
Rafarma Pharmaceuticals |
4Front Ventures Corp |
Rafarma Pharmaceuticals and 4Front Ventures Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Rafarma Pharmaceuticals and 4Front Ventures
The main advantage of trading using opposite Rafarma Pharmaceuticals and 4Front Ventures positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rafarma Pharmaceuticals position performs unexpectedly, 4Front Ventures can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 4Front Ventures will offset losses from the drop in 4Front Ventures' long position.Rafarma Pharmaceuticals vs. 4Front Ventures Corp | Rafarma Pharmaceuticals vs. BellRock Brands | Rafarma Pharmaceuticals vs. Elixinol Global |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |